Updated July 28 at 12:28pm
Health Services
681 results total, viewing 591 - 600
CVS Health Corp. is laying off approximately 150 employees next month, including 70 at its headquarters here, as part of an operational review, according to a company spokesman. more
Novartis AG began selling the first copy of a biotechnology drug in the U.S., offering a 15 percent discount to the original after a U.S. appeals court rejected Amgen Inc.’s last-ditch effort to protect its blockbuster cancer drug Neupogen. more
CVS Health is expanding its approach to telehealth by working with three different telehealth providers, the company announced Wednesday. more
Two local health care providers have among the lowest heart attack mortality rates in the nation – Miriam Hospital in Providence and Southcoast Health in New Bedford, according to Becker’s Hospital Review. more
Federal, state and a welter of community leaders recently participated in a kickoff event at Rhode Island College for Rhode Island’s own series of rallies marking National Recovery Month. more
Medical science in the Brown University Department of Health Services, Policy and Practice as well as research health scientist at the Providence Veterans Administration Medical Center discusses a study establishing the effectiveness of flu vaccines among the elderly. more
The Autism Project and Bristol Rotary Charities Foundation recently announced a new East Bay Support Center to serve individuals with autism spectrum disorder (ASD), as well as their families and the clinicians who support them. more
Citing research indicating a tamping down of smoking rates around the United States resulting from its decision to stop selling tobacco, CVS Health recently observed the one-year anniversary of its new way of doing business. more
The four members of Rhode Island’s congressional delegation all recently received petitions from individuals representing One Degree, a nationwide effort to increase medical research at the National Cancer Institute by $1 billion over two years. more
The U.K.’s health-cost regulator turned down Amgen Inc.’s new cholesterol medicine Repatha in a preliminary ruling, saying the drugmaker may have over-estimated the risk of heart disease that results from people having too much cholesterol. more
« Prev | 1 57 | 58 | 59 | 60 | 61 | 62 | 63 69 | Next »